Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis
出版年份 2015 全文链接
标题
Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 11, Pages 3282-3290
出版商
Baishideng Publishing Group Inc.
发表日期
2017-09-18
DOI
10.3748/wjg.v21.i11.3282
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis
- (2014) R. W. Stidham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of infliximab in treating patients with ulcerative colitis: Experiences from a single medical center in southern China
- (2014) You Lian Zhou et al. Journal of Digestive Diseases
- Adalimumab in active ulcerative colitis: A “real-life” observational study
- (2013) Alessandro Armuzzi et al. DIGESTIVE AND LIVER DISEASE
- Mitochondrial Gene Polymorphisms That Protect Mice From Colitis
- (2013) Florian Bär et al. GASTROENTEROLOGY
- Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
- (2013) Nabeel Khan et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience
- (2013) Stephen J Halpin WORLD JOURNAL OF GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis
- (2011) A.A. Fasanmade et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort
- (2010) N. Gies et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
- (2009) Waqqas Afif et al. INFLAMMATORY BOWEL DISEASES
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
- (2008) E.F. Stange et al. Journal of Crohns & Colitis
- Long-term outcome after infliximab for refractory ulcerative colitis
- (2008) Marc Ferrante et al. Journal of Crohns & Colitis
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now